Arthur Przybyl
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Arthur Przybyl
Earlier roles on record: CEO at Ani Pharmaceuticals Inc (ANIP) until May 10, 2020. The proxy statement of Ani Pharmaceuticals Inc reports total compensation of $857,814 for Arthur Przybyl in fiscal 2020, including a base salary of $332,847. Disclosed compensation is on record for 4 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2020-05-10
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Ani Pharmaceuticals Inc (ANIP) | Former President and Chief Executive Officer | $332,847 | $857,814 |
| 2019 | Ani Pharmaceuticals Inc (ANIP) | Former President and Chief Executive Officer | $776,767 | $5,815,760 |
| 2018 | Ani Pharmaceuticals Inc (ANIP) | Former President and Chief Executive Officer | $726,925 | $4,197,933 |
| 2017 | Ani Pharmaceuticals Inc (ANIP) | President, Chief Executive Officer and Director | $647,270 | $3,580,292 |
Recent activity
No call appearances or filed executive changes recorded yet.